AcariaHealth Sparks Innovation at 2025 Healthcare Advocate Summit with Hackathon and Expert Panels
AcariaHealth, a specialty pharmacy solutions provider and Centene Corporation (NYSE: CNC) subsidiary, will host multiple sessions at the 2025 Healthcare Advocate Summit in Las Vegas from September 2-5, 2025.
The company will lead a pioneering "Reimagine Access" Hackathon featuring themed breakout discussions on healthcare access challenges, including biosimilars, home infusion, and Medicare/Medicaid access. Additionally, AcariaHealth will present an expert panel on biosimilars and market disruption, and a roundtable discussion on the Medicare Prescription Payment Plan (M3P).
Led by CEO Jessica Ciccolella-Kahl, these sessions demonstrate AcariaHealth's commitment to improving healthcare access through innovation and advocacy in specialty pharmacy services.
AcariaHealth, fornitore di soluzioni per farmacie specialistiche e controllata di Centene Corporation (NYSE: CNC), ospiter脿 pi霉 sessioni al 2025 Healthcare Advocate Summit a Las Vegas dal 2 al 5 settembre 2025.
L'azienda guider脿 un innovativo "Reimagine Access" Hackathon con discussioni a tema su sfide di accesso alla salute, inclusi biosimilari, infusioni domiciliari e accesso a Medicare/Medicaid. Inoltre, AcariaHealth presenter脿 un panel di esperti sui biosimilari e le disruptive del mercato, e una tavola rotonda sul Medicare Prescription Payment Plan (M3P).
Guidate dalla CEO Jessica Ciccolella-Kahl, queste sessioni dimostrano l'impegno di AcariaHealth nel migliorare l'accesso alle cure attraverso l'innovazione e l'advocacy nei servizi di farmacia specializzata.
AcariaHealth, proveedor de soluciones para farmacias especializadas y filial de Centene Corporation (NYSE: CNC), organizar谩 varias sesiones en el 2025 Healthcare Advocate Summit en Las Vegas del 2 al 5 de septiembre de 2025.
La compa帽铆a encabezar谩 un innovador "Reimagine Access" Hackathon con mesas de trabajo tem谩ticas sobre los retos de acceso a la atenci贸n sanitaria, incluidos los biosimilares, la infusi贸n domiciliaria y el acceso a Medicare/Medicaid. Adem谩s, AcariaHealth presentar谩 un panel de expertos sobre biosimilares y la disrupci贸n del mercado, y una mesa redonda sobre el Medicare Prescription Payment Plan (M3P).
Bajo la direcci贸n de la CEO Jessica Ciccolella-Kahl, estas sesiones muestran el compromiso de AcariaHealth para mejorar el acceso a la atenci贸n mediante la innovaci贸n y la defensa en los servicios de farmacia especializada.
AcariaHealth電� 鞝勲 鞎疥淡 靻旊（靺� 鞝滉车鞐呾泊鞚挫瀽 Centene Corporation (NYSE: CNC)鞚� 鞛愴殞靷, 2025雲� 9鞗� 2鞚茧秬韯� 5鞚缄箤歆� 霛检姢氩犾澊瓯办姢鞐愳劀 鞐措Μ電� 2025 Healthcare Advocate Summit鞐愳劀 鞐煬 靹胳厴鞚� 欤检禍頃╇媹雼�.
須岇偓電� 鞚橂 鞝戧芳靹� 瓿检牅毳� 欤检牅搿� 頃� 攵勱臣 韱犽鞚� 韽暔頃� 靹犽弰鞝侅澑 "Reimagine Access" 頃挫护韱�鞚� 欤缄磤頃橂┌, 鞐赴鞐愲姅 氚旍澊鞓れ嫓氚�霟�, 臧�鞝� 欤检瀰(頇� 鞚疙摠鞝�), 氅旊敂旒�鞏�/氅旊敂旒�鞚措摐 鞝戧芳靹� 霌膘澊 韽暔霅╇媹雼�. 霕愴暅 AcariaHealth電� 氚旍澊鞓れ嫓氚�霟檧 鞁滌灔 順茧瀫(霐旍姢霟届厴)鞐� 甏�頃� 鞝勲臧� 韺剱瓿� Medicare Prescription Payment Plan(M3P)鞐� 甏�頃� 鞗愴儊 韱犽鞚� 歆勴枆頃╇媹雼�.
CEO 鞝滌嫓旃� 旃橃綔霠愲澕-旃�(Jessica Ciccolella-Kahl)鞚� 鞚措亜電� 鞚措煬頃� 靹胳厴霌れ潃 鞝勲 鞎疥淡 靹滊箘鞀� 攵勳暭鞐愳劀 順侅嫚瓿� 鞓鬼樃 頇滊彊鞚� 韱淀暣 鞚橂 鞝戧芳靹膘潉 頄レ儊頃橂牑電� AcariaHealth鞚� 鞚橃毳� 氤挫棳欷嶋媹雼�.
AcariaHealth, fournisseur de solutions pour pharmacies sp茅cialis茅es et filiale de Centene Corporation (NYSE: CNC), animera plusieurs sessions au 2025 Healthcare Advocate Summit 脿 Las Vegas du 2 au 5 septembre 2025.
L'entreprise dirigera un pionnier "Reimagine Access" Hackathon comprenant des discussions en sous-groupes th茅matiques sur les d茅fis d'acc猫s aux soins, notamment les biom茅dicaments biosimilaires, l'infusion 脿 domicile et l'acc猫s 脿 Medicare/Medicaid. De plus, AcariaHealth pr茅sentera un panel d'experts sur les biosimilars et la disruption du march茅, ainsi qu'une table ronde sur le Medicare Prescription Payment Plan (M3P).
Men茅es par la PDG Jessica Ciccolella-Kahl, ces sessions illustrent l'engagement d'AcariaHealth 脿 am茅liorer l'acc猫s aux soins gr芒ce 脿 l'innovation et au plaidoyer dans les services de pharmacie sp茅cialis茅e.
AcariaHealth, ein Anbieter von Specialty-Pharmacy-L枚sungen und Tochtergesellschaft der Centene Corporation (NYSE: CNC), wird mehrere Sitzungen beim 2025 Healthcare Advocate Summit in Las Vegas vom 2. bis 5. September 2025 veranstalten.
Das Unternehmen wird einen wegweisenden "Reimagine Access" Hackathon durchf眉hren, der thematische Breakout-Diskussionen zu Herausforderungen beim Gesundheitszugang umfasst, darunter Biosimilars, Heiminfusionen und Zugang zu Medicare/Medicaid. Au脽erdem pr盲sentiert AcariaHealth ein Expertengremium zu Biosimilars und Marktdisruption sowie eine Gespr盲chsrunde zum Medicare Prescription Payment Plan (M3P).
Unter der Leitung der CEO Jessica Ciccolella-Kahl zeigen diese Sitzungen AcariaHealths Engagement, den Zugang zur Gesundheitsversorgung durch Innovation und Interessenvertretung im Bereich der Specialty-Pharmacy-Dienstleistungen zu verbessern.
- None.
- None.
Reimagine Access: A Hackathon for Healthcare Advocates
Tuesday, Sept. 2 | 1:00鈥�3:30 PM PT | Florentine 1鈥�11
This dynamic, hands-on session brings together healthcare advocates, providers, and pharmacy professionals for fast-paced, themed breakout discussions focused on real-world access challenges:
- Breaking Bio 鈥� Biosimilars & Continuity of Care
- No Place Like Home 鈥� Reimagining Home Infusion
- Coverage Unlocked 鈥� Medicare/Medicaid Access
- The Access Avengers 鈥� SP + Advocate Partnerships
- Pharmaformers 鈥� Transforming Specialty Pharmacy
Guided by AcariaHealth Regional Sales Directors, each table invites participants to brainstorm actionable solutions they can take back to their organizations.
Expert Panel: Biosimilars & Market Disruption
Thursday, Sept. 4 | 1:30鈥�2:20 PM PT
Join AcariaHealth leaders as they break down biosimilar trends, payer mandates, and how to prevent care disruption. Featuring spotlighting our on provider-pharmacy collaboration.
Panelists:
- Alysha Robinson, PharmD, CSP 鈥� Director, Specialty Pharmacy Program Management
- Kathleen聽Stenberg, PharmD, CSP 鈥� Lead Specialty Pharmacist, Operational Excellence
- Robin聽Waida 鈥� Director, Physician Sales
- Gil Rosas, BSN 鈥� Account Executive
Can't attend?
Roundtable: M3P Unpacked 鈥� Your Final Questions, Clarified
Friday, Sept. 5 | 8:30鈥�9:30 AM PT | Pompeian 1鈥�11
厂辫别补办别谤:听Sheri Wallace - Account Executive
Wrap up the Summit with this interactive discussion on the Medicare Prescription Payment Plan (M3P) and its implications for patients and advocates. No slides鈥攋ust your questions answered.
Advancing Access, Together
"At AcariaHealth, we believe access to care should be as seamless as the care itself," said Jessica Ciccolella-Kahl, CEO of AcariaHealth. "We're proud to lead these conversations and help drive lasting solutions."
From biosimilar transitions to breakthrough collaborations, AcariaHealth is committed to reshaping specialty pharmacy through innovation, advocacy, and compassion.
Heading to the聽? Stop by our sessions, meet the team, and for live updates.
About AcariaHealth
AcariaHealth is a national specialty pharmacy dedicated to supporting patients with complex conditions through personalized care and clinical expertise. As a Centene company, AcariaHealth leverages the strength of the largest Medicaid managed care organization to deliver transformative outcomes across the country.
Learn more:聽
Follow us on聽
View original content to download multimedia:
SOURCE AcariaHealth
FAQ
When and where is AcariaHealth presenting at the 2025 Healthcare Advocate Summit?
What is the 'Reimagine Access' Hackathon by AcariaHealth (NYSE: CNC)?
Who are the speakers for AcariaHealth's biosimilar panel at the 2025 Healthcare Summit?
What topics will AcariaHealth cover in their M3P roundtable discussion?
